Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1969 | 5138 | 29.4 | 71% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
128 | 64704 | GASTROINTESTINAL STROMAL TUMOR//SARCOMA//SOLITARY FIBROUS TUMOR |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2064 | 2302 | SOFT TISSUE SARCOMA//RETROPERITONEAL SARCOMA//RETROPERITONEAL SARCOMAS |
8944 | 1135 | SYNOVIAL SARCOMA//SYT SSX//SYT |
12156 | 864 | TRABECTEDIN//ET 743//YONDELIS |
18468 | 485 | RENIERAMYCIN//QUINOCARCIN//SAFRAMYCIN |
21675 | 352 | ALVEOLAR SOFT PART SARCOMA//ALVEOLAR SOFT PART SARCOMA ASPS//ALVEOLAR SOFT PART |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SYNOVIAL SARCOMA | Author keyword | 817 | 80% | 10% | 513 |
2 | SOFT TISSUE SARCOMA | Author keyword | 429 | 48% | 13% | 650 |
3 | ALVEOLAR SOFT PART SARCOMA | Author keyword | 268 | 86% | 3% | 136 |
4 | RETROPERITONEAL SARCOMA | Author keyword | 177 | 87% | 2% | 87 |
5 | SYT SSX | Author keyword | 172 | 98% | 1% | 45 |
6 | TRABECTEDIN | Author keyword | 146 | 71% | 2% | 117 |
7 | SARCOMA | Author keyword | 91 | 16% | 10% | 520 |
8 | ET 743 | Author keyword | 76 | 85% | 1% | 40 |
9 | SOFT TISSUE SARCOMAS | Author keyword | 74 | 45% | 2% | 123 |
10 | ECTEINASCIDIN 743 | Author keyword | 35 | 81% | 0% | 21 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SYNOVIAL SARCOMA | 817 | 80% | 10% | 513 | Search SYNOVIAL+SARCOMA | Search SYNOVIAL+SARCOMA |
2 | SOFT TISSUE SARCOMA | 429 | 48% | 13% | 650 | Search SOFT+TISSUE+SARCOMA | Search SOFT+TISSUE+SARCOMA |
3 | ALVEOLAR SOFT PART SARCOMA | 268 | 86% | 3% | 136 | Search ALVEOLAR+SOFT+PART+SARCOMA | Search ALVEOLAR+SOFT+PART+SARCOMA |
4 | RETROPERITONEAL SARCOMA | 177 | 87% | 2% | 87 | Search RETROPERITONEAL+SARCOMA | Search RETROPERITONEAL+SARCOMA |
5 | SYT SSX | 172 | 98% | 1% | 45 | Search SYT+SSX | Search SYT+SSX |
6 | TRABECTEDIN | 146 | 71% | 2% | 117 | Search TRABECTEDIN | Search TRABECTEDIN |
7 | SARCOMA | 91 | 16% | 10% | 520 | Search SARCOMA | Search SARCOMA |
8 | ET 743 | 76 | 85% | 1% | 40 | Search ET+743 | Search ET+743 |
9 | SOFT TISSUE SARCOMAS | 74 | 45% | 2% | 123 | Search SOFT+TISSUE+SARCOMAS | Search SOFT+TISSUE+SARCOMAS |
10 | ECTEINASCIDIN 743 | 35 | 81% | 0% | 21 | Search ECTEINASCIDIN+743 | Search ECTEINASCIDIN+743 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ECTEINASCIDIN 743 | 220 | 73% | 3% | 166 |
2 | SYT | 169 | 76% | 2% | 118 |
3 | ADJUVANT BRACHYTHERAPY | 167 | 96% | 1% | 51 |
4 | ET 743 | 161 | 83% | 2% | 90 |
5 | SYT SSX | 118 | 90% | 1% | 52 |
6 | ECTEINASCIDIN 743 ET 743 | 113 | 92% | 1% | 45 |
7 | SSX FUSION TYPE | 105 | 80% | 1% | 66 |
8 | SSX | 99 | 78% | 1% | 66 |
9 | LIMB SPARING SURGERY | 93 | 60% | 2% | 103 |
10 | EXTREMITY | 90 | 21% | 8% | 392 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A Review of Trabectedin (ET-743): A Unique Mechanism of Action | 2010 | 92 | 35 | 91% |
Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics | 2002 | 470 | 183 | 96% |
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics | 2015 | 2 | 104 | 69% |
Development of Yondelis (R) (trabectedin, ET-743). A semisynthetic process solves the supply problem | 2009 | 87 | 71 | 76% |
Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer | 2015 | 2 | 61 | 44% |
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment | 2014 | 7 | 40 | 80% |
Recent progress in the total synthesis of naphthyridinomycin and lemonomycin tetrahydroisoquinoline antitumor antibiotics (TAAs) | 2008 | 54 | 39 | 95% |
Soft Tissue Sarcomas: Staging Principles and Prognostic Nomograms | 2015 | 1 | 39 | 79% |
Medical progress: Soft-tissue sarcomas in adults | 2005 | 273 | 87 | 49% |
Management of Recurrent Retroperitoneal Sarcoma | 2014 | 6 | 44 | 86% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SARCOMA UNIT | 18 | 32% | 0.9% | 45 |
2 | ADULT SARCOMA MED TREATMENT UNIT | 11 | 100% | 0.1% | 6 |
3 | BONE SOFT TISSUE SARCOMAS | 9 | 83% | 0.1% | 5 |
4 | INTERDISCIPLINARY SARCOMA | 6 | 80% | 0.1% | 4 |
5 | SARCOMA BONE ONCOL | 6 | 25% | 0.4% | 21 |
6 | UNIV MUSCULOSKELETAL ONCOL UNIT | 5 | 31% | 0.3% | 15 |
7 | BIOACT NAT PROD MARINE ORGANISMS ENDOPHYT F | 5 | 37% | 0.2% | 10 |
8 | MULTIDISCIPLINARY SARCOMA | 4 | 67% | 0.1% | 4 |
9 | BUCHA T ONCOL AL T TIOREANU | 4 | 75% | 0.1% | 3 |
10 | SARCOMA DIS MANAGEMENT TEAM | 4 | 56% | 0.1% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000032688 | LIPOBLASTOMA//LIPOSARCOMA//LIPOMA |
2 | 0.0000031454 | RHABDOMYOSARCOMA//EWINGS SARCOMA//DESMOPLASTIC SMALL ROUND CELL TUMOR |
3 | 0.0000023466 | ENDOMETRIAL STROMAL SARCOMA//LEIOMYOSARCOMA//UTERINE SARCOMA |
4 | 0.0000019061 | SOLITARY FIBROUS TUMOR//DERMATOFIBROSARCOMA PROTUBERANS//HEMANGIOPERICYTOMA |
5 | 0.0000015979 | GASTROINTESTINAL STROMAL TUMOR//GIST//GASTROINTESTINAL STROMAL TUMORS |
6 | 0.0000015712 | CHORDOMA//ANEURYSMAL BONE CYST//OSTEOID OSTEOMA |
7 | 0.0000015576 | ANGIOSARCOMA//EPITHELIOID HEMANGIOENDOTHELIOMA//INTRAVASCULAR LYMPHOMA |
8 | 0.0000015143 | ISOLATED LUNG PERFUSION//PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY//PULMONARY ALVEOLAR MICROLITHIASIS |
9 | 0.0000009081 | WILMS TUMOR//WT1//RHABDOID TUMOR |
10 | 0.0000008955 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE |